## Core Concept
The core concept being tested here involves the mechanism of entry of the Human Immunodeficiency Virus (HIV) into its target cells, specifically focusing on the step of cell fusion. HIV, like other enveloped viruses, enters the host cell through a process that involves the fusion of its viral envelope with the host cell membrane.

## Why the Correct Answer is Right
The correct answer, **gp41**, is a subunit of the HIV envelope glycoprotein complex. The HIV envelope contains two glycoproteins: gp120 and gp41. gp120 is responsible for binding to the CD4 receptor on the surface of T helper cells and other target cells. After gp120 binds to CD4, it undergoes a conformational change that exposes gp41. gp41 then inserts into the host cell membrane and facilitates the fusion of the viral envelope with the host cell membrane, allowing the viral capsid to release its genetic material into the host cell. This process is crucial for the replication of HIV.

## Why Each Wrong Option is Incorrect
- **Option A:** While **gp120** is indeed a part of the HIV envelope glycoprotein complex and is involved in the initial attachment to the CD4 receptor on host cells, it does not directly facilitate cell fusion.
- **Option B:** This option might seem plausible due to the context but does not directly relate to the specific step of cell fusion as accurately as gp41 does.
- **Option D:** Similarly, this option does not directly relate to the specific mechanism of cell fusion in the context of HIV entry.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the process of HIV entry into cells is a critical target for antiretroviral therapy (ART). Specifically, drugs that target the fusion process, such as enfuvirtide (T-20), work by binding to gp41 and preventing it from facilitating membrane fusion, thereby inhibiting viral entry into host cells.

## Correct Answer: C. gp41.